169 related articles for article (PubMed ID: 22409649)
1. Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.
Del Pup L
Gynecol Endocrinol; 2012 Sep; 28(9):740-5. PubMed ID: 22409649
[TBL] [Abstract][Full Text] [Related]
2. Effect of one-month treatment with vaginal promestriene on serum estrone sulfate levels in cancer patients: a pilot study.
Del Pup L; Postruznik D; Corona G
Maturitas; 2012 May; 72(1):93-4. PubMed ID: 22349253
[TBL] [Abstract][Full Text] [Related]
3. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
Al-Baghdadi O; Ewies AA
Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
[TBL] [Abstract][Full Text] [Related]
4. Vaginal estrogens for the treatment of dyspareunia.
Krychman ML
J Sex Med; 2011 Mar; 8(3):666-74. PubMed ID: 21091878
[TBL] [Abstract][Full Text] [Related]
5. Managing postmenopausal vaginal atrophy. Vaginal dryness is one of the most irritating symptoms of menopause. Here are some ways to relieve it.
Harv Womens Health Watch; 2010 Mar; 17(7):4-5. PubMed ID: 20480969
[No Abstract] [Full Text] [Related]
6. Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
Archer DF
Menopause; 2010; 17(1):194-203. PubMed ID: 19602990
[TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone intra vaginal administration for the management of postmenopausal vulvovaginal atrophy.
Archer DF
J Steroid Biochem Mol Biol; 2015 Jan; 145():139-43. PubMed ID: 25201455
[TBL] [Abstract][Full Text] [Related]
8. Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy.
Simon JA; Maamari RV
Climacteric; 2013 Aug; 16 Suppl 1():37-43. PubMed ID: 23848490
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intravaginal 6.5mg (0.50%) prasterone, 0.3mg conjugated estrogens and 10μg estradiol on symptoms of vulvovaginal atrophy.
Archer DF; Labrie F; Montesino M; Martel C
J Steroid Biochem Mol Biol; 2017 Nov; 174():1-8. PubMed ID: 28323042
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a non-hormonal intravaginal moisturizer for the treatment of vaginal dryness in postmenopausal women with sexual dysfunction.
Vale F; Rezende C; Raciclan A; Bretas T; Geber S
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():92-95. PubMed ID: 30677618
[TBL] [Abstract][Full Text] [Related]
11. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
Edwards D; Panay N
Climacteric; 2016 Apr; 19(2):151-61. PubMed ID: 26707589
[TBL] [Abstract][Full Text] [Related]
12. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study.
Bachmann GA; Komi JO;
Menopause; 2010; 17(3):480-6. PubMed ID: 20032798
[TBL] [Abstract][Full Text] [Related]
13. Vaginal pH: a simple assessment highly correlated with vaginal morphology and symptoms in postmenopausal women.
Tucker KM; Godha K; Mirkin S; Archer DF
Menopause; 2018 Jul; 25(7):762-766. PubMed ID: 29509598
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial on the effectiveness and safety of 5 water-based personal lubricants.
Palacios S; Hood S; Abakah-Phillips T; Savania N; Krychman M
J Sex Med; 2023 Mar; 20(4):498-506. PubMed ID: 36781402
[TBL] [Abstract][Full Text] [Related]
15. I stopped taking oral estrogen pills, and now vaginal dryness is a problem. My doctor suggested I use a vaginal cream containing estrogen. Is estrogen given this way absorbed by the body?
Mayo Clin Health Lett; 2003 Aug; 21(8):8. PubMed ID: 12971311
[No Abstract] [Full Text] [Related]
16. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
Kagan R; Williams RS; Pan K; Mirkin S; Pickar JH
Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the management of postmenopausal vaginal atrophy.
Sturdee DW; Panay N;
Climacteric; 2010 Dec; 13(6):509-22. PubMed ID: 20883118
[TBL] [Abstract][Full Text] [Related]
18. Use of Growth Factors for Vulvo/Vaginal Bio-Stimulation.
Isaza PG
Surg Technol Int; 2019 May; 34():269-273. PubMed ID: 30388724
[TBL] [Abstract][Full Text] [Related]
19. Effects of vaginally delivered estrogens.
Heimer G; Samsioe G
Acta Obstet Gynecol Scand Suppl; 1996; 163():1-2. PubMed ID: 8916468
[TBL] [Abstract][Full Text] [Related]
20. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
